hepat
c
viru
hcv
major
global
health
burden
world
popul
chronic
infect
persist
infect
lead
cirrhosi
hepatocellular
carcinoma
recent
avail
treatment
option
show
enhanc
efficaci
viru
clearanc
associ
resist
signific
side
effect
warrant
research
basic
understand
viral
protein
pathophysiolog
protein
hcv
integr
membran
protein
form
ionchannel
role
hcv
life
cycl
present
uncertain
research
perform
date
highlight
role
viru
assembl
process
aim
review
provid
overview
literatur
investig
structur
function
detail
summar
develop
date
regard
potenti
compound
better
understand
protein
may
lead
develop
new
effect
therapi
hepat
c
viru
hcv
infect
global
health
problem
estim
million
peopl
infect
worldwid
levrero
chronic
infect
individu
develop
cirrhosi
hepatocellular
carcinoma
common
clinic
outcom
thoma
combin
pegyl
interferon
alpha
ribavirin
current
standard
care
associ
poor
toler
variabl
efficaci
recent
increas
sustain
virolog
respons
hcv
treatment
achiev
use
directact
antivir
compound
combin
ribavirin
unfortun
proteas
inhibitor
suscept
develop
resist
associ
advers
side
effect
addit
alreadi
observ
canon
treatment
fortun
addit
promis
antivir
compound
line
analysi
develop
includ
novel
class
inhibitor
avail
clinic
near
futur
feld
hoofnagl
believ
greater
understand
intricaci
protein
function
viral
life
cycl
provid
insight
inform
plausibl
lead
broader
rang
better
treatment
option
hcv
belong
hepaciviru
genu
within
flavivirida
famili
singlestrand
rna
genom
posit
polar
classif
hcv
expand
includ
seven
discern
differ
genotyp
multipl
subtyp
kuiken
simmond
hcv
mainli
infect
hepatocyt
sequenti
bind
multipl
host
receptor
scaveng
receptor
class
b
type
low
densiti
lipoprotein
ldl
occludin
synergist
promot
tight
bind
intern
virion
next
poorli
understood
phdepend
fusion
uncoat
step
take
place
releas
viral
genom
cytoplasm
hcv
entri
review
zeisel
et
al
viral
rna
genom
recogn
host
ribosom
via
intern
ribosom
entri
site
ire
sequenc
locat
end
untransl
region
utr
order
mediat
viral
genom
translat
translat
polypeptid
chain
approxim
amino
acid
aa
long
coand
posttransl
process
hostand
virusencod
proteas
associ
endoplasm
reticulum
er
gener
individu
matur
form
viral
protein
fig
hoffman
liu
envelop
glycoprotein
well
core
protein
compris
physic
structur
virion
nonstructur
ns
protein
form
complex
perform
viral
rna
amplif
hcv
rna
replic
review
moradpour
et
al
mani
protein
also
interact
way
support
viral
assembl
et
al
masaki
et
al
jone
et
al
kohlway
et
al
han
et
al
viral
protein
involv
viral
rna
replic
jirasko
et
al
jirasko
et
al
popescu
et
al
stapleford
lindenbach
transmembran
autoproteas
compos
two
domain
ntermin
membran
anchor
ctermin
cystein
proteas
mediat
cleavag
adjac
protein
translat
hijikata
et
al
lorenz
et
al
requir
hcv
infect
vivo
viru
product
hcv
cell
cultur
system
pietschmann
et
al
kolykhalov
et
al
shown
homodimer
interact
viral
protein
includ
interact
led
suggest
major
role
hcv
assembl
process
jirasko
et
al
jirasko
et
al
stapleford
lindenbach
dimitrova
et
al
yi
et
al
past
hcv
research
hinder
inabl
studi
viru
context
complet
life
cycl
replicon
system
systemat
breakthrough
har
neomycin
select
gene
ecmv
ire
mediat
translat
hcv
ns
protein
enabl
rna
replic
vitro
lohmann
et
al
consid
replicon
system
fail
yield
infecti
translat
initi
ire
intern
ribosom
entri
site
sequenc
within
utr
gener
polypeptid
chain
compris
unprocess
structur
protein
core
envelop
glycoprotein
blue
box
middl
panel
well
nonstructur
protein
red
box
viral
protein
neither
structur
nonstructur
protein
green
box
polypeptid
undergo
coand
posttransl
process
er
gener
matur
form
viral
protein
enzymat
digest
site
indic
symbol
bottom
panel
defin
inset
viru
structur
protein
express
develop
pseudoparticl
system
hcvpp
partial
fill
gap
hcvpp
system
exploit
retroviru
biolog
creat
chimer
virus
contain
hcv
glycoprotein
surfac
system
cell
use
gener
particl
contain
particl
could
use
infect
permiss
hepatocyt
cell
line
entri
could
analyz
use
report
gene
luciferas
gfp
recombin
construct
bartosch
et
al
hsu
et
al
discoveri
hepat
c
viru
cell
cultur
system
hcvcc
provid
investig
capac
studi
whole
hcv
life
cycl
includ
assembl
releas
therebi
open
door
mutagenesi
studi
viral
protein
order
identifi
individu
function
interact
within
hcv
life
cycl
lindenbach
et
al
wakita
et
al
zhong
et
al
hcvcc
system
revolv
around
replic
power
genotyp
genotyp
construct
wakita
et
al
yi
et
al
system
provid
insight
capabl
implement
adapt
mutat
chimer
construct
increas
viral
titer
facilit
assess
genotyp
variabl
pietschmann
et
al
lindenbach
et
al
russel
et
al
viru
assembl
process
initi
recruit
core
surfac
lipid
droplet
ld
erassoci
organel
primarili
function
store
neutral
lipid
cholesterol
ester
believ
provid
platform
nucleocapsid
format
boulant
et
al
mclauchlan
et
al
viral
rna
packag
downstream
envelop
step
still
poorli
understood
believ
support
commun
replic
complex
matur
virion
jirasko
et
al
stapleford
lindenbach
phan
et
al
boson
et
al
assembl
process
hypothes
coincid
host
vldl
pathway
newlyform
virion
releas
lipovir
particl
lvp
hcv
assembl
review
hcv
protein
locat
matur
form
length
lin
et
al
artifici
lipid
membran
perform
ionchannel
activ
therefor
includ
group
viral
protein
term
viroporin
griffin
et
al
protein
known
modul
membran
permeabl
support
viru
entri
assembl
releas
viroporin
review
nieva
et
al
depend
genotyp
activ
hinder
multipl
ionchannel
blocker
amantadin
rimantadin
iminosugar
deriv
griffin
et
al
griffin
et
al
pavlov
et
al
foster
et
al
addit
dispens
viral
rna
replic
import
vivo
infect
chimpanze
model
product
infecti
hcvcc
sakai
et
al
brohm
et
al
atoom
et
al
function
hcv
life
cycl
remain
matter
debat
multipl
studi
place
role
late
stage
viru
assembl
process
atoom
et
al
gentzsch
et
al
review
aim
summar
function
structur
comprehens
achiev
date
field
firmli
believ
repres
attract
target
novel
hcv
treatment
better
understand
function
utmost
import
develop
comprehens
therapeut
regimen
hcv
process
topolog
local
protein
identifi
express
seri
ctermin
truncat
hcv
polyprotein
fuse
human
cmyc
epitop
tag
analysi
locat
envelop
glycoprotein
protein
fig
lin
et
al
homolog
protein
identifi
pestiviru
genu
eg
bovin
viral
diarrhea
viru
bvdv
classic
swine
fever
viru
border
diseas
viru
contain
characterist
protein
elber
et
al
howev
flavivirus
yellow
fever
viru
dengu
viru
west
nile
viru
encod
protein
homolog
murray
et
al
upon
hcv
genom
translat
process
mediat
hostencod
proteas
fig
mclauchlan
et
al
reed
rice
scission
junction
delay
result
presenc
precursor
polyprotein
cleavag
junction
incomplet
perform
uniqu
mammalian
signal
peptidas
lead
presenc
matur
form
well
speci
lin
et
al
dubuisson
et
al
mizushima
et
al
partial
cleavag
attribut
structur
determin
locat
ntermin
signal
peptid
support
find
fusion
report
protein
ntermin
signal
peptid
improv
cleavag
effici
carrerekrem
et
al
function
precursor
yet
unidentifi
hypothes
develop
precursor
play
role
hcv
life
cycl
ii
precursor
could
import
regul
kinet
andor
level
final
product
express
prevent
prematur
viru
assembl
carrerekrem
et
al
shanmugam
yi
case
illustr
coordin
cleavag
cprem
murray
valley
enceph
viru
stock
lobig
iii
precursor
might
import
pull
physic
composit
virion
retain
pool
er
form
griffin
et
al
howev
like
cleavag
precursor
play
regulatori
role
complet
separ
insert
emcv
ire
two
protein
moder
reduc
level
viru
product
hcvcc
system
suggest
precursor
serv
function
purpos
tempor
depend
process
critic
viru
product
shanmugam
yi
transcomplement
studi
found
whether
alon
context
cleavag
intermedi
suffici
restor
viru
product
depend
extent
origin
delet
degre
indirect
effect
delet
polyprotein
process
brohm
et
al
summari
clear
process
intermedi
way
impact
viru
product
whether
intermedi
specif
function
within
viral
life
cycl
requir
investig
protein
polytop
membran
protein
cross
endoplasm
membran
twice
form
transmembran
domain
transmembran
domain
connect
short
segment
fig
b
nand
ctermini
orient
toward
cytosol
lin
et
al
subcellular
local
identifi
fusion
myc
fusion
cell
identifi
larg
fraction
earli
compart
secretori
pathway
suggest
presenc
retent
signal
maintain
local
er
carrerekrem
et
al
convers
intracellular
stain
gfpor
flagtag
cell
show
partial
coloc
mitochondria
adjac
membran
structur
griffin
et
al
interestingli
stain
nativ
tag
demonstr
untag
exclus
detect
er
ntermin
tag
detect
er
mitochondri
adjac
membran
work
indic
complex
traffick
could
regul
cleavag
upstream
signal
peptid
target
signal
present
within
protein
sequenc
griffin
et
al
immunofluoresc
electron
microscopi
em
context
fulllength
rna
replicationcompet
hcv
genom
deriv
sequenc
show
tag
ha
downstream
potenti
cleavag
site
local
er
cell
howev
import
note
tag
like
disrupt
viru
product
haqshena
et
al
consequ
recent
studi
doublehatag
nterminu
genotyp
chimer
construct
contain
gene
junction
point
within
creat
viabl
viru
replic
viru
show
signific
coloc
er
marker
lesser
extent
associ
mitochondri
lipid
droplet
marker
show
reticular
stain
pattern
mainli
coloc
hcv
partial
vieyr
et
al
hypothet
local
multipl
organel
may
indic
protein
dual
role
hcv
assembl
traffick
nascent
virion
multipl
cellular
pathway
rel
small
size
membran
integr
topolog
made
analysi
local
function
labori
sometim
inconclus
possibl
access
antibodi
durat
infect
chosen
abovement
literatur
inaccur
identifi
local
multipl
cellular
compart
therefor
sensit
proteom
analysi
track
local
multipl
separ
cellular
organel
variou
time
hcv
infect
cell
cultur
need
order
gain
reliabl
insight
role
hcv
life
cycl
protein
bvdv
hcv
origin
propos
oligomer
form
ionchannel
harada
et
al
carrerekrem
et
al
respect
oligimer
observ
shown
form
hexam
artifici
membran
function
calcium
ionchannel
black
lipid
membran
ionchannel
activ
assay
could
abrog
drug
amantadin
griffin
et
al
ionchannel
activ
crosslink
lead
inclus
protein
viroporin
famili
consist
small
hydrophob
protein
abil
permeabil
membran
ion
small
molecul
movement
exampl
list
tabl
review
nieva
et
al
gonzalez
carrasco
wang
et
al
liang
li
ruch
macham
import
exampl
viral
protein
influenza
viru
form
proton
ionchannel
activ
acid
environ
trigger
viral
uncoat
entri
within
acid
endosom
protect
ha
glycoprotein
prematur
matur
transgolgi
network
egress
indic
multitud
function
perform
viral
encod
ionchannel
channel
activ
block
amantadin
rimantadin
suggest
two
could
use
treat
influenza
infect
review
kelli
et
al
schnell
chou
conduct
across
artifici
lipid
membran
confirm
pentam
format
shown
necessari
accommod
ion
transport
studi
also
report
concentrationdepend
inhibit
channel
activ
treatment
longalkylchain
iminosugar
deriv
nnonyl
deoxygalactonojirimycin
nndgj
nnonyl
deoxynojirimycin
nndnj
pavlov
et
al
compound
test
potent
antivir
activ
bvdv
cellbas
assay
griffin
et
al
demonstr
express
mammalian
cell
substitut
influenza
viru
channel
activ
maintain
infect
influenza
activ
also
could
block
antivir
drug
amantadin
addit
also
shown
mutat
two
basic
residu
within
cytoplasm
loop
abrog
ionchannel
activ
highlight
import
loop
function
griffin
et
al
subsequ
studi
confirm
ionchannel
function
planar
lipid
bilay
membran
show
channel
permeabl
potassium
sodium
ion
limit
permeabl
calcium
ion
premkumar
et
al
later
fluorescencebas
liposom
assay
develop
conveni
assay
channel
activ
therapeut
target
within
employ
assay
use
genotyp
show
dosedepend
releas
fluoresc
indic
mix
liposom
releas
activ
block
drug
amantadin
rimantadin
sever
relat
compound
stgelai
et
al
taken
togeth
similar
protein
function
inhibit
provid
strong
evid
also
viroporin
investig
sequenc
determin
critic
ionchannel
activ
drug
sensit
led
number
insight
outcom
concern
role
put
channel
one
report
show
leucinerich
motif
ctermin
end
partial
contribut
drug
sensit
mutat
two
basic
residu
within
cytoplasm
loop
found
affect
channel
activ
caus
disrupt
ionchannel
insert
membran
histidin
residu
also
show
signific
effect
ionchannel
function
stgelai
et
al
part
hxxx
yw
like
motif
also
found
influenza
integr
ionchannel
open
meshkat
et
al
shown
critic
posit
ion
pore
demonstr
key
role
ionchannel
conduct
addit
mutat
polymorph
hcv
found
confer
adamantan
iminosugar
resist
respect
foster
et
al
find
highlight
import
mutat
analys
sequenc
associ
ionchannel
activ
major
implic
drug
bind
potenti
identif
novel
inhibitor
channel
activ
never
test
cell
culturebas
assay
recapitul
entir
hcv
life
cycl
system
hcvcc
establish
lindenbach
et
al
wakita
et
al
zhong
et
al
contrast
earlier
studi
discrep
observ
hcvcc
system
employ
character
potenti
antivir
effect
amantadin
iminosugar
deriv
nndgj
nndnj
nbdnj
found
amantadin
affect
viru
releas
infect
ionchannel
activ
chimer
genom
contrarili
iminosugar
deriv
reduc
viru
titer
dosedepend
manner
context
multipl
genotyp
primarili
viru
assembl
releas
step
iminosugar
deriv
nndgj
nndnj
nbdnj
shown
also
target
cellular
ii
inhibit
lead
misfold
variou
host
bergeron
et
al
viral
glycoprotein
bvdv
hiv
fischer
et
al
mind
abovement
effect
iminosugar
deriv
viru
product
could
attribut
alter
hcv
envelop
protein
shown
previous
manipul
host
cellular
glycoprotein
crucial
viru
propag
cell
cultur
similar
discrep
also
observ
relat
protein
call
gbvb
wherebi
amantadin
inhibit
function
ionchannel
activ
fail
inhibit
replic
secret
gbvb
virallyinfect
marmoset
hepatocyt
premkumar
et
al
develop
hcvcc
system
introduc
greater
opportun
character
griffin
et
al
extens
differenti
genotypeand
subtypedepend
sensit
multipl
inhibitor
use
hcvcc
artifici
membran
assay
found
isol
block
amantadin
hcvcc
liposomebas
assay
wherea
amantadin
success
inhibit
system
amantadin
inhibit
rimantadin
abl
inhibit
channel
activ
viru
product
addit
iminosugar
deriv
nndgj
nndnj
reduc
infecti
viru
product
genotyp
dosedepend
manner
observ
effect
viral
protein
synthesi
process
hcv
rna
replic
cellular
cytotox
griffin
et
al
differ
result
obtain
variou
inhibitor
context
differ
genotyp
contrast
result
suggest
inhibitor
may
need
develop
genotypespecif
manner
interestingli
ionchannel
activ
identifi
nativ
cell
membran
vesicl
infect
cell
measur
h
proton
conduct
fluoresc
detect
lysosom
ph
indic
similarli
express
cell
equilibr
h
conduct
hcv
infect
increas
lysosom
ph
infect
cell
defect
ionchannel
mutant
yield
increas
furthermor
amantadin
rimantadin
hexamethylen
amilorid
block
h
conduct
nativ
vesicular
membran
wozniak
et
al
recent
articl
atkin
et
al
tabl
exampl
known
viroporin
ionchannel
name
respect
viru
famili
name
shown
column
known
expect
function
list
column
number
monom
need
form
channel
upon
oligomer
classif
shown
column
potenti
inhibitor
column
abbrevi
ha
hemagglutinin
human
immunodefici
viru
type
vpu
viral
protein
u
cov
coronaviru
tabl
inform
gather
refer
nieva
et
al
gonzalez
carrasco
wang
et
al
liang
li
ruch
macham
provid
new
evid
suggest
directli
influenc
ph
matur
via
yet
undefin
mechan
atkin
et
al
strongli
advoc
import
ionchannel
activ
viru
propag
small
compound
term
shown
inhibit
hiv
product
late
stage
viral
life
cycl
block
vpu
ionchannel
activ
imped
viru
releas
monocytederiv
macrophag
khouri
et
al
also
shown
bind
use
comput
model
monom
along
amantadin
rimantadin
nndnj
shown
inhibit
ionchannel
activ
lipid
membran
demonstr
antivir
activ
bvdv
infect
assay
small
number
clinic
trial
includ
potenti
inhibitor
perform
date
combin
therapi
amantadin
exhibit
insignific
correl
amino
acid
variat
within
respons
treatment
individu
howev
mutat
observ
often
nonrespond
patient
infect
receiv
combin
therapi
give
weight
theori
amantadin
target
mihm
et
al
subsequ
increas
earli
virolog
respons
observ
patient
treat
ribavirin
amantadin
yet
sustain
virolog
respons
rate
remain
arm
receiv
standard
care
castelain
et
al
earli
inhibit
observ
previous
combin
amantadin
ribavirin
shown
reduc
plasma
viral
rna
level
patient
phase
trial
lake
bakaar
et
al
data
indic
amantadin
could
use
case
new
infect
promot
viral
decay
establish
persist
infect
still
prematur
includ
ionchannel
inhibitor
ribavirin
discrep
observ
among
inhibit
studi
perform
date
could
attribut
system
inconsist
eg
artifici
membran
liposom
assay
hcvcc
andor
use
dissimilar
genotyp
studi
nativ
form
versu
tag
version
protein
clinic
trial
data
still
confin
respons
rate
lack
drug
deliveri
analysi
plausibl
account
minim
therapeut
outcom
complet
extens
mutat
analys
could
structur
function
understand
ionchannel
identifi
specif
region
within
could
repres
novel
therapeut
target
subsequ
concomit
analys
patient
genom
clinic
trial
could
provid
penetr
inform
concern
resist
suscept
region
nmr
structur
analysi
perform
show
ntermin
portion
form
form
connect
short
loop
howev
structur
featur
helix
length
observ
nmr
contrast
molecular
model
carrerekrem
et
al
stgelai
et
al
clark
et
al
patargia
et
al
monomer
nmr
structur
unveil
dynam
natur
structur
identifi
predict
multifunct
protein
rather
one
strictli
act
ionchannel
cook
et
al
also
monomer
nmr
structur
analysi
perform
identifi
relev
alloster
caviti
compat
drug
bind
find
highlight
import
potenti
target
develop
hcv
inhibitor
foster
et
al
nmr
data
obtain
oligomer
indic
protein
form
hexamer
channel
complex
presenc
deterg
em
analysi
identifi
flowerlik
shape
six
distinct
petal
helic
orient
toward
lumen
er
identifi
structur
also
show
access
area
face
interior
er
could
provid
interact
face
viral
host
protein
luik
et
al
addit
sequenc
assembl
sequenti
form
oligomer
structur
four
seven
subunit
put
function
oligom
hexam
cylindr
structur
accommod
flowerlik
shape
sequenti
format
channel
suggest
regul
function
wherebi
would
retain
inact
state
allow
bind
viral
protein
earli
assembl
process
subsequ
pore
format
could
take
place
accommod
channel
activ
requir
later
stage
life
cycl
chandler
et
al
recent
nmr
structur
identif
ionchannel
show
sequenc
form
unusu
hexamer
complex
funnellik
shape
see
fig
b
studi
also
suggest
amantadin
rimantadin
bind
six
equival
hydrophob
pocket
poreform
peripher
helic
defin
possibl
mechan
inhibit
action
ouyang
et
al
divers
structur
predict
base
nmr
analys
may
attribut
number
variabl
differ
genotyp
amino
acid
sequenc
purif
method
use
solvent
environment
condit
use
prepar
protein
nmr
structur
analys
howev
structur
agreement
nmr
studi
prove
import
identif
structur
featur
monomer
oligomer
structur
well
drug
bind
determin
within
delet
mutat
two
conserv
posit
charg
residu
cytoplasm
loop
within
infecti
clone
fail
caus
viremia
intrahepat
transfect
chimpanze
model
furthermor
substitut
infecti
clone
also
viabl
result
clearli
demonstr
import
viru
life
cycl
vivo
well
restrict
genotyp
context
function
sakai
et
al
given
accumul
evid
suggest
form
ionchannel
act
viroporin
conceiv
activ
might
requir
viru
facilit
entri
assembl
releas
manner
similar
viroporin
griffin
et
al
pavlov
et
al
premkumar
et
al
develop
hcvcc
system
mutagenesi
studi
variou
viral
protein
function
analysi
becam
possibl
lindenbach
et
al
wakita
et
al
zhong
et
al
earli
mutat
analys
demonstr
import
viru
product
steinmann
et
al
show
involv
late
stage
replic
cycl
sinc
mutant
reduc
total
infect
ratio
intracellular
releas
infecti
particl
success
shown
less
like
involv
viral
entri
process
due
mainten
specif
infect
observ
releas
virion
genom
mutat
subsequ
studi
illustr
mutant
genom
gener
lower
level
intracellular
viru
releas
core
protein
infecti
particl
cultur
supernat
suggest
involv
earli
stage
viral
morphogenesi
cycl
lab
creat
extens
set
tripl
alanin
mutat
cover
cytoplasm
loop
atoom
et
al
mutant
subject
transfect
singlecycl
viru
product
assay
employ
subclon
cell
term
cell
russel
et
al
cell
express
significantli
lower
level
hcv
entri
receptor
permit
rna
replic
viru
product
support
entri
therebi
allow
gener
infecti
viru
without
confound
effect
multipl
infect
cycl
use
assay
illustr
import
domain
mainten
infecti
viru
product
atoom
et
al
current
number
convinc
piec
evid
exist
suggest
involv
entri
step
viral
life
cycl
hcv
pseudoparticl
hcvpp
produc
cell
lack
remain
infecti
hepatocytederiv
cell
line
bartosch
et
al
ii
cisexpress
hcvpp
product
increas
infect
flint
et
al
iii
hcv
virion
acidresist
suggest
ionchannel
activ
entri
need
tschern
et
al
iv
relat
viru
bvdv
found
compon
virion
structur
elber
et
al
v
character
adapt
mutat
found
increas
level
extracellular
viru
particl
even
viru
entrynul
system
atoom
et
al
manuscript
prepar
vi
importantli
use
infecti
construct
contain
doubl
hatag
found
contain
within
virion
even
concentr
affinitypurifi
flagtag
prepar
viru
vieyr
et
al
thing
consid
viroporinlik
activ
might
requir
step
downstream
viru
entri
resembl
influenza
activ
viral
egress
vpu
see
tabl
regard
step
subsequ
viral
entri
current
evid
indic
role
rna
replic
replicon
lack
replic
effici
cell
lohmann
et
al
blight
et
al
ii
bvdv
contain
mutat
abl
replic
cell
cultur
fail
produc
infecti
particl
harada
et
al
iii
mutat
delet
within
gener
context
hcvcc
replic
rna
effici
impair
infecti
viru
product
establish
hcvcc
system
facilit
mani
studi
could
perform
past
result
hcv
assembl
process
becam
intens
investig
one
intrigu
aspect
assembl
mechan
accumul
core
protein
around
cellular
organel
term
lipid
droplet
ld
propos
function
platform
viru
assembl
miyanari
et
al
found
efficientlyassembl
adapt
strain
well
genom
mutat
cytoplasm
loop
show
differ
abil
associ
core
ld
atoom
et
al
howev
other
suggest
core
accumul
ld
context
efficientlyassembl
viru
suggest
coreld
accumul
indic
assembl
defect
boson
et
al
worth
mention
assemblydefici
hcv
strain
could
rescu
compensatori
mutat
restor
viru
product
coloc
site
close
proxim
ld
jirasko
et
al
correspondingli
report
visual
manipul
intracellular
distribut
disrupt
bind
pattern
viral
protein
et
al
assumpt
confirm
recent
show
distribut
affect
presenc
ntermin
signal
peptid
tedburi
et
al
present
differ
perspect
effici
core
accumul
ld
due
mutat
quantifi
found
mutat
cytoplasm
loop
affect
unload
core
protein
ld
result
retent
core
around
ld
preced
observ
could
indic
import
coloc
ld
process
crucial
function
interestingli
also
shown
import
unload
newlyform
capsid
toward
assembl
matur
envelop
popescu
et
al
gentzsch
et
al
subsequ
core
protein
recruit
ld
core
oligomer
form
capsid
structur
presum
facilit
format
multiord
form
morphogenesi
cycl
would
includ
monomer
core
partial
oligom
fulli
oligomer
capsid
virion
associ
triglycerid
would
show
differ
densiti
upon
intracellular
lysat
fraction
andr
et
al
gastaminza
et
al
jone
et
al
other
shown
mutat
cytoplasm
loop
prevent
assembl
corecontain
intracellular
particl
iodixanol
equilibrium
gradient
sediment
atoom
et
al
bentham
et
al
compellingli
anoth
report
perform
core
quantit
fraction
obtain
sucrosebas
rate
zonal
fraction
observ
increas
proport
incomplet
assembl
capsid
analys
fraction
indic
mutat
delet
cytoplasm
loop
led
accumul
nonenvelop
capsid
transfect
cell
data
reflect
necess
downstream
capsid
format
postul
function
ionchannel
gain
momentum
shown
hcv
infect
equilibr
intracellular
acid
vesicl
loss
acid
observ
hcv
genom
harbor
ionchannel
defect
mutat
sequenc
found
intracellular
hcv
virion
acidsensit
wherea
extracellular
virion
acidst
confirm
find
acidif
inhibitor
bafilomycin
abl
rescu
viru
product
ionchannel
defect
mutant
wozniak
et
al
moreov
found
tripl
alanin
substitut
amino
acid
residu
rgr
aaa
reduc
amount
present
hcvtransfect
cell
h
posttransfect
atoom
et
al
furthermor
hcv
replicationdefect
virus
contain
mutat
cytoplasm
loop
show
restor
infect
tran
express
proton
channel
influenza
indic
ionchannel
requir
hcv
propag
cell
cultur
bentham
et
al
interestingli
proteinas
k
digest
mutant
virus
show
signific
reduct
core
protein
indic
nucleocapsid
lack
envelop
demonstr
affect
viru
product
step
prior
envelop
ionchannel
activ
could
import
step
protect
immatur
virion
acid
environ
late
stage
assembl
particularli
envelop
step
summat
clear
import
factor
viru
product
specif
late
stage
viral
assembl
might
dual
function
protein
one
aspect
presum
monomer
form
assist
gather
newlyform
capsid
ld
glycoprotein
complex
er
lumen
proper
envelop
wherea
oligomer
state
protect
glycoprotein
immatur
degrad
traffick
releas
ionchannellik
activ
third
possibl
receiv
littl
attent
date
may
play
yet
undetermin
function
involv
interact
cellular
factor
regard
suggest
modul
cell
death
signal
may
target
cellular
kinas
aweya
et
al
lee
et
al
would
interest
know
interact
cellular
protein
order
promot
viru
product
bind
pattern
viral
protein
continu
reveal
geneticsbas
investig
proteinprotein
interact
analys
first
clue
concern
necess
interact
protein
came
intrahepat
rna
inject
chimpanze
chimer
viru
gener
replac
sequenc
result
chimera
viabl
inject
illustr
genotypespecif
interact
sakai
et
al
infecti
clone
use
multipl
studi
gener
infecti
chimera
replac
case
core
part
fragment
sequenc
genotyp
case
observ
chimer
virus
viabl
genotyp
homolog
substitut
structur
gene
characterist
chimera
construct
suggest
import
interplay
one
structur
protein
pietschmann
et
al
gottwein
et
al
yi
et
al
success
creat
viabl
chimer
construct
fuse
site
within
passag
allow
accumul
adapt
compensatori
mutat
result
chimera
acquir
mutat
within
combin
mutat
increas
specif
infect
suggest
interact
interact
propos
anchor
within
membran
therebi
enhanc
abil
protect
nascent
virion
prematur
inactiv
yi
et
al
furthermor
compensatori
mutat
significantli
enhanc
fit
defect
core
mutant
context
chimera
provid
genet
evid
interact
core
taken
togeth
remain
unlik
protein
size
interact
multipl
viral
protein
said
possibl
interact
singl
viral
protein
order
stabil
downstream
interact
promot
viral
propag
biochem
proteom
assay
also
use
identifi
bind
partner
one
report
util
tag
show
effici
pulldown
lower
extent
jirasko
et
al
work
shown
coimmunoprecipit
well
et
al
importantli
mutagenesi
studi
demonstr
affect
coloc
around
ld
basic
loop
mutat
significantli
reduc
interact
jirasko
et
al
et
al
noteworthi
mutat
two
basic
residu
cytoplasm
loop
caus
consider
alter
intracellular
distribut
et
al
howev
difficult
conclud
whether
result
indic
direct
interact
loop
remov
charg
residu
chang
topolog
indirectli
affect
local
protein
recent
confirm
interact
mutat
chang
subcellular
local
reduc
viral
assembl
popescu
et
al
interact
shown
independ
ionchannel
activ
local
affect
primarili
signal
peptid
nterminu
suggest
altern
function
assembl
process
tedburi
et
al
recent
coimmunoprecipit
studi
use
replicationcompet
viru
contain
doubl
hatag
confirm
specif
interact
propos
critic
viru
product
cell
cultur
vieyr
et
al
despit
discrep
observ
bind
partner
conclud
maintain
organ
viral
assembl
process
mandatori
interact
partner
also
plausibl
bind
manner
regul
function
viru
assembl
size
topolog
made
poorli
immunogen
antibodi
product
consequ
determin
bind
partner
standard
method
problemat
difficult
interpret
topolog
membran
structur
data
gener
purifi
tag
protein
might
reflect
actual
pictur
consid
exist
multipl
form
unprocess
monomer
oligom
reproduc
data
becom
complic
accordingli
accur
experiment
approach
need
investig
identifi
better
defin
proteinprotein
interact
activ
viral
potenti
cellular
requir
vivo
infect
import
infecti
viru
product
cell
cultur
unknown
reason
cleavag
adjac
viral
protein
delay
lead
presenc
precursor
polypeptid
propos
regulatori
role
viru
product
recent
structur
topolog
studi
confirm
mainli
local
er
contain
two
transmembran
domain
connect
short
cytoplasm
loop
oligomer
membran
believ
form
ionchannel
facilit
proton
permeabil
order
equilibr
intracellular
vesicl
ph
promot
infecti
viru
product
ionchannel
activ
inhibit
sever
compound
iminosugar
deriv
show
promis
result
moreov
interact
support
late
step
viral
assembl
envelop
interact
pattern
viral
host
factor
exact
contribut
infecti
viru
product
remain
ambigu
opinion
contrast
hypothes
field
regard
function
partli
stem
fact
numer
system
employ
analyz
protein
artifici
membran
singl
protein
express
hcvcc
hcvcc
tag
although
relev
system
provid
critic
inform
regard
difficult
reconcil
variou
result
perhap
greatest
limit
face
present
lack
reliabl
monoclon
antibodi
recogn
gener
would
major
advanc
would
allow
relev
analysi
unmodifi
context
full
viral
genom
